Why XRD?
XRD is essential in identifying and quantifying solid-state-forms of active pharmaceutical ingredients (API), including crystalline polymorphs, hydrates, and amorphous phases. These forms influence drug stability, solubility, and bioavailability.
XRD can also be used for quality control purposes, helping to detect crystalline or amorphous impurities, phase transitions, and batch-to-batch variability in both APIs and formulations.
Why Aeris?
Higher quality powder data
Aeris offers low-noise, high-resolution, and truly reproducible XRD measurements in both reflection and transmission modes. Aeris’s high sensitivity helps you identify potential contamination, enhancing product quality and minimizing risks.
Robust method development with HighScore
When combined with HighScore software, Aeris allows users to handle a wide range of analytical tasks, including:
- Phase identification
- Phase quantification (single to multiple phases)
- Testing limits of detection
- Crystallinity determination
21 CFR Part 11 compliance support with OmniTrust
Designed with the help of industry experts, our OmniTrust software defines user roles according to your workflow and tracks every interaction with Aeris, from creating measurement routines to reviewing data.
System controls prevent errors and help to ensure regulatory compliance. Potential issues with data integrity are instantly identifiable and accessible for review, saving you time and reducing stress.
Learn more about Aeris Pharma edition